-
To the future with the original heart, to build new brilliance - Shenzhen Cell Valley 2024 annual management summary meeting was successfully heldOn January 16, 2025, Shenzhen Cell Valley successfully held the 2024 annual management summary meeting, chaired by Chairman and General manager Shi Yuanyuan...01-17 -
Chairman Shi Yuanyuan attended the third meeting of the Advisory Committee and Policy Advisory Committee of Pingshan ICH ParkOn December 12, Shi Yuanyuan, chairman of our company, attended the "Third Meeting of Pingshan ICH Park Advisory Committee and Policy Advisory Committe...01-15 -
Shenzhen Cell Valley wholly-owned subsidiary Junhou biological innovation research team project launch meeting was successfully held近期，深圳細(xì)胞谷全資子公司廣東君厚生物醫(yī)藥有限公司榮獲2022年中山市第九批創(chuàng)新科研團(tuán)隊(duì)項(xiàng)目立項(xiàng)并獲得數(shù)百萬元政府支持資金。 Recently, Guangdong Junhou Biomedicine Co., LTD., a wholly-owned subsidiary of Shenzhen Cell V...01-15 -
Guangdong Junhou Biomedicine Co., Ltd. won the ISO9001 quality management system certificationOn October 27, 2022, Guangdong Junhou Biopharmaceutical Co., LTD., a wholly-owned subsidiary of Shenzhen Cell Valley Biopharmaceutical Co., LTD. (hereinafte...01-15 -
Shi Yuanyuan was invited to attend the closed-door meeting of industry leaders at the 2022 Shenzhen International Biomedical Industry Innovation and Development ConferencOn the afternoon of November 2, Shi Yuanyuan, chairman of our company, was invited to attend the closed-door meeting of industrial leaders of the 2022 Shenzhen ...01-15 -
Help NK cell therapy - Shenzhen Cell Valley and Enkesai reach a comprehensive strategic cooperationFrom September 26 to 27, 2022, Professor Shi Yuanyuan, Chairman of Shenzhen Cell Valley Biomedicine Co., LTD., Professor Wang Jianxun, Chief scientist of Shenzh...01-15
